Aft, Forsyth & Company, Inc. Abb Vie Inc. Transaction History

Aft, Forsyth & Company, Inc.

$199 Million
Q3 2024

A detailed history of Aft, Forsyth & Company, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 6,318 shares of ABBV stock, worth $1.11 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

6,318

Previous 6,543 3.44%

Holding current value

$1.11 Million

Previous $1.12 Million 11.14%

% of portfolio

0.63%

Previous 0.58%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $36,864 - $44,849	-225 Reduced 3.44%	6,318 $1.25 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $113,770 - $132,858	735 Added 12.65%	6,543 $1.12 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $117,467 - $133,843	-735 Reduced 11.23%	5,808 $1.06 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $10,320 - $11,622	-75 Reduced 1.13%	6,543 $1.01 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $9,938 - $12,367	75 Added 1.15%	6,618 $891,000
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $4,338 - $4,996	-30 Reduced 0.46%	6,543 $1.04 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $23,956 - $30,312	-223 Reduced 3.28%	6,573 $890,000
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Reduced 2.86%	6,796 $733,000
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $19,884 - $22,152	189 Added 2.78%	6,996 $788,000
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $402 - $543	-5 Reduced 0.07%	6,807 $729,000
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $19,329 - $22,686	-225 Reduced 3.2%	6,812 $597,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $27,807 - $37,210	-379 Reduced 5.11%	7,037 $691,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $17,737 - $26,892	275 Added 3.85%	7,416 $565,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $69,592 - $83,670	-1,105 Reduced 13.4%	7,141 $541,000
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $21,352 - $27,293	325 Added 4.1%	8,246 $600,000
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $102,210 - $120,296	-1,325 Reduced 14.33%	7,921 $638,000
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $24,912 - $30,723	-320 Reduced 3.35%	9,246 $852,000
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $8,713 - $9,686	-98 Reduced 1.01%	9,566 $905,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $38,156 - $45,147	425 Added 4.6%	9,664 $895,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $830,298 - $1.11 Million	-9,024 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $808,189 - $886,247	9,024	9,024 $873,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.

Account

Aft, Forsyth & Company, Inc. Abb Vie Inc. Transaction History